All eyes on Senate after House passes user fee reauthorization bill

Regulatory NewsRegulatory NewsAPIsBiologicsBiotechnologyClinical TrialsCombination ProductsDiagnosticsMedical DevicesNorth AmericaOTCPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and DevelopmentSupply Chain Management